Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMG-guided vs Conventional Botox for Gummy Smile
NCT06075134Recruiting
- Sponsor
- Cairo University
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A in excessive gingival display (2 arms), sponsored by Cairo University. Primary endpoint: Change in amount of gingival display at 6 months. Started Nov 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT06075134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06075134.